News
BAYRY
15.36
-0.52%
-0.08
Bayer (0P6S) Receives a Hold from Berenberg Bank
TipRanks · 16h ago
Janux Therapeutics: Potential JANX007 Comeback mCRPC And Initial JANX011 Data
Seeking Alpha · 1d ago
Weekly Report: what happened at BAYRY last week (1109-1113)?
Weekly Report · 2d ago
Bayer Advances Elinzanetant Formulation Study as Menopause Market Competition Builds
TipRanks · 6d ago
Bayer’s Sunharbo approved by FDA to reduce risk of stroke
TipRanks · 11/10 17:31
Bayer New Stroke Drug Can Withstand Competition -- Market Talk
Dow Jones · 11/10 14:05
Bayer (0P6S) Gets a Buy from Deutsche Bank
TipRanks · 11/10 09:55
Jefferies Reaffirms Their Hold Rating on Bayer (0P6S)
TipRanks · 11/10 08:55
Reported Earlier, Bayer’s SUNHARBO Receives FDA Approval As First Factor XIa Inhibitor, Reducing Ischemic Stroke 6.2% Versus 8.4% For Placebo In 12,327-Patient Phase 3 OCEANIC-STROKE Study
Benzinga · 11/10 06:50
Bayer gains approval of Factor XIa inhibitor asundexian to reduce stroke risk
Seeking Alpha · 11/10 02:08
ValuEngine Weekly Market Commentary With Outlook For The Remainder Of 2026
Seeking Alpha · 11/09 20:02
Weekly Report: what happened at BAYRY last week (1102-1106)?
Weekly Report · 11/09 09:34
Calley Means accuses Wiles of putting fundraising over MAHA agenda
Seeking Alpha · 11/06 20:09
Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)
TipRanks · 11/04 17:46
Deutsche Bank Remains a Buy on Bayer (0P6S)
TipRanks · 11/04 13:49
UBS Reaffirms Their Buy Rating on Bayer (0P6S)
TipRanks · 11/04 13:49
Bayer Earnings Call Signals Growth Amid Ongoing Risks
TipRanks · 11/04 00:09
Bayer AG: Solid Q3 Earnings, But Still A 'Prove-It' Story
Seeking Alpha · 11/03 18:54
Bayer to Present New Cardiovascular, Kidney and Stroke Data at the 2026 American Heart Association (AHA) Scientific Sessions
Barchart · 11/03 13:30
J.P. Morgan Reaffirms Their Buy Rating on Bayer (0P6S)
TipRanks · 11/03 12:53
More
Webull provides a variety of real-time BAYRY stock news. You can receive the latest news about Bayer Aktien through multiple platforms. This information may help you make smarter investment decisions.
About BAYRY
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.